Parkinson Disease: all 4,583 studies
Page 40 of 46. Open to participants first (1,097), then studies with results posted, then the rest; newest registration first within each.
- EEG and Pharmacological Exploration of Executive Dysfunctions Induced by STN-DBS in PDCompletedNCT01796483Not applicable
- Role of Mesocorticolimbic Pathway in Apathy of Patients With Parkinson's Disease. - Study Using Diffusion Tensor Imaging and Fibres TrackingCompletedNCT01794195Not applicable
- Cognitive Phenotypes in Parkinson's DiseaseCompletedNCT01792843
- Gut-derived Neuropeptides in Cerebrospinal Fluid of Patients With Parkinson's Disease and Healthy ControlsCompletedNCT01792193
- Anesthesia for Deep Brain StimulationCompletedNCT01789385Phase 4
- Pilot Study To Assess Effect of Treatment and Adherence in PD SubjectsCompletedNCT01788696Phase 1
- Effect of Deep Brain Stimulation on Gait of Patients With Parkinson's Disease Depending on Electrode Location in Subthalamic AreaCompletedNCT01782638Phase 4
- Role of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian PatientsStatus unknownNCT01780467Phase 4
- Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF EpisodesCompletedNCT01777555Phase 2
- Speech Intelligibility of Patients With P D Compared to First Degree Relatives of P D PatientsStatus unknownNCT01776879
- Investigating the Pathophysiological Roles of Cortical, Sub-thalamic Nuclear and Pedunculo-pontine Nuclear Oscillation in Movement Termination of Parkinson Disease PatientsCompletedNCT01774383
- Freezing of Gait Correction and Fall Prevention: Developing a Real-time Somatosensory Stimulation SystemStatus unknownNCT01772186Not applicable
- The Effect of Low Frequency STN DBS on Sleep and Vigilance in Parkinson's Disease (PD) PatientsCompletedNCT01769690Not applicable
- Parkinson's Disease Biomarker ProgramCompletedNCT01767818
- Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor FluctuationsCompletedNCT01766258Phase 2
- Study of Zonisamide in Early Parkinson DiseaseWithdrawnNCT01766128Phase 2/3
- Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center StudyStatus unknownNCT01765257Phase 4
- Evaluation of Directional Stimulation During the Implantation of Deep Brain Stimulation (DBS) LeadsCompletedNCT01764815Not applicable
- Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 ParkinsonismCompletedNCT01759888Phase 2
- A Randomized Controlled Feasibility Trial to Determine the Effectiveness of Set Dancing for People With Parkinson's DiseaseCompletedNCT01757509Not applicable
- Amyloid Beta and Cognition in Parkinson DiseaseCompletedNCT01754168
- Exercise Intervention and Dexterity in ParkinsonCompletedNCT01749917Not applicable
- Physiopathological Study of Autonomic Failure in Parkinson's DiseaseCompletedNCT01748409Not applicable
- Circadian Rhythms and Sleep-Wake Cycles in Parkinson's DiseaseCompletedNCT01742182Not applicable
- Effects of Physical Activity on the Brain in Parkinson's Disease (PD)CompletedNCT01741584Not applicable
- Caffeine as a Therapy for Parkinson's DiseaseCompletedNCT01738178Phase 3
- Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor FluctuationsCompletedNCT01736891Phase 3
- Effects of Tactile Touch on Chronic Pain in Parkinson´s DiseaseCompletedNCT01734876Not applicable
- Open-label Investigation of the Safety and Clinical Effects of NTCELL in Patients With Parkinson's DiseaseCompletedNCT01734733Phase 1/2
- Behavioural Addictions Occurring During a Dopaminergic Treatment Prescribe Under Parkinson's Disease: Study of the Psychopathological, Neurological, Pharmacokinetic and Genetic ProfilesCompletedNCT01733199Phase 4
- A Treadmill Training Program Augmented by Virtual Reality to Decrease Fall Risk in Older AdultsCompletedNCT01732653Not applicable
- A Longitudinal Study in Parkinson's Disease (PD) PatientsStatus unknownNCT01730599
- Investigation of Road-crossing Safety Before and After Training Between Parkinson Disease Pedestrians and Older PedestriansStatus unknownNCT01727687Not applicable
- A Safety, Tolerability, and Plasma Concentration Study of Levodopa/Carbidopa Subcutaneous Solution (ND0612) in Parkinson's Disease (PD) PatientsCompletedNCT01725802Phase 1
- Education in Therapy of Parkinson's DiseaseCompletedNCT01717144Not applicable
- Diagnosis of Parkinson's Disease Using Diffusion Magnetic Resonance ImagingCompletedNCT01715727
- Continuation Treatment Protocol for Patients Who Participated in the Adagio TVP 1012/501 Clinical TrialStatus unknownNCT01709461
- Behavior Addictions Improvement in Parkinson Disease's Patients Treated by Subthalamic Stimulation : Long Term Follow-upCompletedNCT01705418
- Fox Investigation for New Discovery of BiomarkersCompletedNCT01705327
- Neurotransmitter Measurements Using (WINCS) During Deep Brain Stimulation NeurosurgeryCompletedNCT01705301
- Nucleus Basalis Deep Brain Stimulation for Thinking & Memory Problems in Parkinson's.CompletedNCT01701544Phase 1/2
- The Effect of Exercise Training on Gait and Quality of Life in Parkinson's DiseaseTerminatedNCT01701128Not applicable
- Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement DisordersCompletedNCT01698450Phase 1
- Web-based International Multi-Center Clinical Study for Parkinson's DiseaseStatus unknownNCT01696812Not applicable
- Phase IIa Multicentre Study Investigating of VR040 in Parkinson's DiseaseCompletedNCT01693081Phase 2
- Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy VolunteersCompletedNCT01691924Phase 1
- A STUDY TO EVALUATE THE EFFICACY OF CJH1 (CLR4001) IN PARKINSON'S DISEASEStatus unknownNCT01684475Phase 1/2
- Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's DiseaseCompletedNCT01683292Phase 2
- Managing Changes in Life After Deep Brain Stimulation for Parkinson's DiseaseCompletedNCT01681641Not applicable
- The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's DiseaseCompletedNCT01676103Phase 1/2
- Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's DiseaseCompletedNCT01673724Phase 4
- Robot Walking Rehabilitation in Parkinson's DiseaseCompletedNCT01668407Not applicable
- Nocturnal Parkinson's Disease Symptoms Study GroupCompletedNCT01662427
- Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's DiseaseCompletedNCT01662414Phase 4
- Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and WomenCompletedNCT01652313Phase 1
- Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Randomised Controlled TrialStatus unknownNCT01650623Not applicable
- Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Study ProtocolStatus unknownNCT01650610Not applicable
- Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson DiseaseCompletedNCT01648803
- Pilot Study to Determine if Working Memory Training Aids Cognitive Functioning in Patients With Parkinson's DiseaseActive, not recruitingNCT01647698Not applicable
- A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's DiseaseCompletedNCT01646333Not applicable
- Effect of Osteopathic Manipulative Medicine (OMM) on Pulmonary Function and Speech in Parkinson's DiseaseCompletedNCT01636011Not applicable
- A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy MenCompletedNCT01634568Phase 1
- Parkinson's Foundation Quality Improvement InitiativeCompletedNCT01629043
- AAV2-GDNF for Advanced Parkinson s DiseaseCompletedNCT01621581Phase 1
- Assessment of Three-dimensional Vision Alteration in Parkinson DiseaseCompletedNCT01620164Not applicable
- Study of the Enteric Nervous System Using Colonic Biopsies in Parkinson Patients With LRRK2 MutationTerminatedNCT01618383Not applicable
- Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" EpisodesCompletedNCT01617135Phase 2
- Non-invasive Neurostimulation in Parkinson's DiseaseCompletedNCT01615718Not applicable
- Mindfulness Based Intervention (MBI) on the Quality of Life and Non-Motor Symptoms (NMS) of Persons With PDCompletedNCT01607697Phase 2
- Effect of Bright Light on Mood and Sleep in Parkinson's DiseaseCompletedNCT01604876Not applicable
- A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's DiseaseCompletedNCT01603069Phase 2
- A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker DiscoveryCompletedNCT01592552
- Emotional and Cognitive Subthalamic Nucleus in Deep Brain Stimulation Treated Parkinson PatientsStatus unknownNCT01590056
- Mobilaser Study to Help With People Who Are Having Problems With Their GaitCompletedNCT01581645Early Phase 1
- Functional Improvement in Patients With Parkinson's Disease After Training in Real or Virtual EnvironmentCompletedNCT01580787Not applicable
- Deep Brain Stimulation Follow-up After 10 YearsStatus unknownNCT01575132
- Decrease in Sense of Smell and Associated Cognitive Decline in Parkinson's DiseaseCompletedNCT01572142
- Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's DiseaseCompletedNCT01568099Phase 1
- PET Study of Non-Motor Symptoms of Parkinson DiseaseCompletedNCT01565473
- Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)WithdrawnNCT01565395Phase 2
- Drug Interaction With Genes in Parkinson's DiseaseStatus unknownNCT01564992
- Postural Instability in Progressive Supranuclear PalsyCompletedNCT01563276
- The ParkCycle Study: Aerobic Exercise in PDCompletedNCT01562496Not applicable
- Disease-modifying Potential of Transdermal NICotine in Early Parkinson's DiseaseStatus unknownNCT01560754Phase 2
- A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement DisordersCompletedNCT01550484Phase 2/3
- Mutations Associated With Parkinson s DiseaseTerminatedNCT01547832
- Cardiovascular Events in Parkinson's Disease PatientsCompletedNCT01545856
- Internet-CBT (Cognitive Behavioral Therapy) for Depression and Anxiety in Parkinsons DiseaseCompletedNCT01545414Phase 3
- Sensory Stimulation Effect on Movement Speed in Patients With Parkinson DiseaseCompletedNCT01544738Not applicable
- Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's DiseaseTerminatedNCT01544465Not applicable
- Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's DiseaseCompletedNCT01538329Phase 2
- PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)CompletedNCT01536821
- Intestinal and Nasal Microbiota of Patients With Idiopathic Parkinson's DiseaseCompletedNCT01536769
- Movement Disorder Quantification Algorithm DevelopmentCompletedNCT01534650
- Effect of BIA 9-1067 on Cardiac Repolarization in Healthy Adult Men and WomenCompletedNCT01532115Phase 1
- Genetic Study in Young Onset Parkinson's DiseaseStatus unknownNCT01529970
- PET Study in Parkinson's Disease PatientsCompletedNCT01527695Phase 2
- Behavioral Therapy to Treat Urinary Symptoms in Parkinson DiseaseCompletedNCT01520948Phase 3
- PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term TherapyCompletedNCT01519856
- Imaging Biomarkers of Delayed Sequelae in Trauma Brain InjuryCompletedNCT01516281